CME Mission Statement
ASCRS’ continuing medical education mission is to improve the competence of ophthalmologists/anterior segment surgeons by offering an avenue for the presentation and discussion of innovative techniques and technologies and fostering an open environment where current practices are presented and questions and improvements in patient care are continually sought.
Accreditation Statement
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
Designation Statement
The American Society of Cataract and Refractive Surgery designates the ASCRS Glaucoma Day for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Physicians can claim CME credit up to the maximum listed above for attending the Physicians Program (ASCRS), including scientific films and posters on-demand, scientific papers, courses, symposia and general sessions). Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Note: All attendees must have their badges to be eligible to claim credits and evaluate the program.
Target Audience:
Practicing ophthalmologists who care for patients with corneal-related conditions.
Educational Objectives:
• Recognize updates in diagnostics for the management of Fuchs Dystrophy
• Compare and contrast best practices and techniques in the treatment of Fuchs
• Summarize treatments for endothelial disease and discuss injectable endothelial cell technology
• Examine office-based corneal disease management; to include the management of keratoconus, corneal collagen crosslinking, herpes eye disease, and infectious keratitis
• Employ strategies for managing complex cornea cases in treating complex DALK, DMEK and PKP challenges
• Examine current research related to the etiology and treatment of severe ocular surface diseases
• Discover treatment options for management of corneal infections and chronic corneal inflammatory disorders
• Develop strategies to identify and efficiently manage patients with dry eye disease
